Table 2:
Summary of known kernicterus and G6PD deficiency rates in various countries | |||||
---|---|---|---|---|---|
Country | Incidence of kernicterus (per 100,000) | % G6PD deficiency in infants with kernicterus | Expected % G6PD deficiency, based on general population | Fold over-representation of G6PD deficiency in infants with kernicterus | Ref |
Canada | 2.3 - 7.9 | 39 - 58 | 0 - 3 | 30 X | 7,75–77 |
Cuba | 4.6 | 5 | 2 - 4 | 1.6 X | 78,79 |
Denmark | 1.8 - 9 | 2 | 0 - 3 | 1 X | 7,80,81 |
Hong Kong | 269 | 55 | 3 - 6 | 12 X | 82 |
Nigeria | 800 - 1600 | 61 - 80 | 15 | 4.7 X | 83–86 |
Oman | 346 | 70 | 18 | 3.9 X | 87 |
Singapore | N/A | 43 | 2 | 22 X | 88 |
Turkey | N/A | 18 | 13 | 1.4 X | 89 |
USA | 1.5 | 20 | 1 - 7 | 5.6 X | 7,18,90 |
UK/Ireland | 0.9 | 21 | 0 - 3 | 13 X | 7,91 |
Average | 7.5 X |